Tag: research

Top Pharmacology Researcher to Oversee School of Medicine’s Pioneering Biomedical Research

Top Pharmacology Researcher to Oversee School of Medicine’s Pioneering Biomedical Research

The School of Medicine has named Jeffrey R. Martens, PhD, as the new Senior Associate Dean for Research.

The University of Virginia School of Medicine has named Jeffrey R. Martens, PhD, an internationally recognized pharmacology researcher, leader, and educator, as the new Senior Associate Dean for Research. Martens will assume his new role on May 15, 2023. 

“Professor Martens will be a key contributor in the transformation of the School of Medicine and UVA Health medical research program, while also managing a rapidly growing portfolio of resources, innovative projects, and talent for the School of Medicine and the greater University,” said Melina R. Kibbe, MD, the dean of the UVA School of Medicine and chief health affairs officer for UVA Health.

Martens comes to UVA from the University of Florida College of Medicine, where he has served as chair of the Department of Pharmacology and Therapeutics for the past eight years. He has driven a 10-fold increase in outside research funding during his tenure. He also spearheaded collaboration within the College of Medicine as well as with research centers and institutes across the University of Florida. In addition, the academic and scientific achievements of his faculty resulted in U.S. News & World Report ranking for Pharmacology and Toxicology at UF in the top 17 nationally, the top nine among public universities and 50th internationally.

The impact of Martens’ research is demonstrated through his long list of peer-reviewed publications and the fact that his research has been continuously funded by the National Institutes of Health, National Science Foundation and the American Heart Association, among others, since 1990. Dr. Martens’ research is focused in two areas of pharmacology and therapeutics, including sensory neuropharmacology and cardiovascular pharmacology, with work in both the heart and olfactory systems.

Martens holds longstanding memberships in several professional societies, including the American Society for Pharmacology and Experimental Therapeutics and the Association of Chemoreception Sciences. He also has served in several editorial board positions for scientific publications, most recently as an editorial advisory board member for Molecular Pharmacology.

Martens earned his bachelor’s degree and doctorate from the University of Florida and did his post-doctoral training at Colorado State University. Before joining the faculty at the University of Florida, Martens was a faculty member at Oregon Health & Science University and the University of Michigan.

“This position at UVA is a new and different opportunity to lead across department boundaries and integrate the School of Medicine’s excellent clinical, translational and basic science efforts,” Martens said. “I am excited to collaborate with the School of Medicine’s world-class faculty and join a respected leadership team at a time of transformational growth.”

He succeeds Linda Duska, MD, MPH, who has served as interim Senior Associate Dean for Research since March 15, 2021. “The strategic guidance, leadership and program oversight Dr. Duska has provided to the School of Medicine has been invaluable,” Kibbe said. “I have extraordinary gratitude for her dedication and commitment to the School of Medicine and UVA Health.”

Duska will continue in her roles as Associate Dean for Clinical Research in the School of Medicine, Vice Chair for Research in the Department of Obstetrics and Gynecology, and as a gynecologic oncologist at the UVA Cancer Center.

FDA Passes New Cannabis Guidance for Clinical Research | Beveridge & Diamond PC

Critical Takeaways

  • What Happened: The Food items and Drug Administration (Food and drug administration) finalized a 2020 draft guidance detailing the agency’s suggestions for scientific analysis for building hashish and cannabis-derived human medication.
  • Who’s Impacted: Individuals associated in the clinical study of hashish can rely on this Food and drug administration guidance for suggested sources of cannabis for medical analysis and sources for facts on high-quality and control status issues. The steerage also suggests strategies for researchers to work out the THC dissimilarities concerning “hemp” and “cannabis.” The guidance can help tell stakeholders, lawmakers, and other folks in the hashish field by addressing particular issues elevated about drugs made up of cannabis and crucial Fda regulatory principles.

History

On January 24, 2023, the Food and drug administration announced new assistance entitled “Cannabis and Hashish-Derived Compounds: Top quality Criteria for Clinical Investigation.” The non-binding guidance discusses a few critical cannabis-associated subjects:

  • Sourcing cannabis for medical analysis
  • How to estimate percent delta-9 tetrahydrocannabinol (THC) all through the study cycle and,
  • Normal high quality considerations for creating human medications that contain hashish and cannabis-derived compounds.

Typically, to be viewed as “hemp,” a merchandise have to incorporate much less than .3 p.c delta-9 THC by dry bodyweight. Anything at all earlier mentioned .3 per cent delta-9 THC is regarded as hashish (or marijuana), a Plan I controlled substance. Human medications that incorporate hemp, hashish, and hashish-derived compounds are commonly subject to the exact same authorities and demands, together with excellent expectations, as Fda-regulated drug solutions that contains any other material.

The target of FDA’s hottest steering is to assist clinical exploration for the growth of hashish and cannabis-derived human prescription drugs. The direction does not handle the progress of thoroughly artificial variations of substances that take place in cannabis and does not deal with other Food and drug administration-regulated items.

Sourcing of Cannabis

The National Institute on Drug Abuse (NIDA) Drug Offer Plan was the only legal resource for scientists to purchase cannabis for many many years. The NIDA Drug Supply Application continues to be a resource of cannabis in excess of the .3 percent delta-9 THC threshold for clinical study. In 2020, the Drug Enforcement Company (DEA) adopted new procedures to permit the registration of new companies to plant, increase, cultivate, or harvest cannabis. There was confusion, even so, over no matter whether medical studies could use these new producers. This guidance intends to make clear that confusion and presents that:

  • For hashish in excess of the .3 {bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} delta-9 THC threshold and not part of an investigational new drug (IND) software – the NIDA Drug Provide Program and other sources authorized by DEA to supply Routine I cannabis resources for research can be made use of.
  • For any cannabis resources (earlier mentioned or beneath the .3 per cent threshold) as part of an IND software- other resources can be utilised matter to the approval of the software.

When the sourcing of hashish for medical analysis has been a apparent location of problem for individuals associated in the scientific research of hashish, the Food and drug administration also presented direction on additional nuanced problems that this sector faces.

Calculation of THC

Farmers and researchers have extended been involved about the calculation of THC, provided the unpredictable nature of the plant. Uncontrollable environmental factors as properly as extraction and manufacturing processes can influence the THC concentration and press lawful hemp into a managed substance. The steering endorses that experts calculate the THC material in their proposed hashish or hashish-derived investigational drug merchandise early in the enhancement procedure to decide their product’s probable abuse legal responsibility and command standing. The direction also discusses the very best calculation approaches all over the lifecycle of medical scientific studies.

Common High-quality Things to consider

As section of an IND for any drug, scientists are envisioned to display that they can continually manufacture a quality product or service. In each stage of clinical investigation, they must post enough details to show the drug’s identity, excellent, purity, and potency. The direction includes added concepts and tips that are specially related for acquiring prescription drugs that consist of cannabis and cannabis-derived compounds:

  • Hashish and cannabis-derived compounds are held to the same regulatory benchmarks as any other botanical uncooked content, botanical drug compound, or botanical drug product. This incorporates making sure batch-to-batch consistency, conducting microbiological exams and sterility assessments, and screening for raw components (between other unique necessities on p. 6 of the guidance).

  • Top quality assessments, particular to dosage type, should be done.
  • Impurities for obviously taking place compounds should be managed.
  • Researchers ought to not count on posted literature in area of details from a total toxicology system, as the certain botanical drug product below evaluate might differ from that of the released examine.
  • Evaluate the metabolic profile of big cannabinoids in human beings early for security.

Impacts

This Fda guidance allows presents clarity to the cannabis marketplace on hashish and hashish-derived drug progress in the wake of Congress passing the Healthcare Marijuana and Cannabidiol Analysis Expansion Act. Stakeholders have been eagerly awaiting updates from the Fda and other federal businesses with regards to the sale and promoting of cannabis-derived merchandise as effectively as a scientific assessment of cannabis to aid reevaluate the substance’s plan under the Controlled Substances Act. As a high precedence of the Biden Administration, we will most likely see numerous important regulatory updates for cannabis in 2023.

Businesses can submit on the web or published comments on this steerage at any time. The tips in this steering are not required or binding – researchers may possibly use an different strategy as extensive as it satisfies the necessities of the relevant statutes and polices.

[View source.]

Florida Atlantic, Broward Health partner on academic medical research

  • Florida Atlantic College and Broward Wellness introduced a new partnership this 7 days that will have interaction the two entities in joint tutorial analysis. 
  • FAU and Broward Wellbeing will also jointly conduct fundraising strategies. 
  • As portion of the arrangement, FAU students in health science diploma tracks will have obtain to physicians and clinical services at Broward Wellness. 
  • The go marks the most up-to-date enlargement to the university’s quickly-developing FAU Wellness community.

Florida Atlantic University (FAU) and Broward Overall health declared a partnership arrangement this week to aid educational medication initiatives together with scientific training, overall health companies, and analysis.

The two entities state they will use the partnership to collaborate on scholar and school investigation and fundraising possibilities. Even further, FAU learners getting health science programs will have entry to physicians and scientific amenities in just Broward Well being as aspect of the arrangement.

“Florida Atlantic University and Broward Overall health share a prevalent vision and purpose of offering significant-excellent and compassionate health care treatment, stellar instruction, and lifesaving exploration close to property,” stated FAU Board of Trustees Chairman Brad Levine. “This collaboration makes us element of a very important network in Broward County that connects us with a associate that will empower us to treatment for our neighborhood.”

The partnership with Broward Wellbeing joins a increasing listing of health care centers affiliated with FAU. Previous June, the university’s Wellbeing method included seven new associates, increasing its access to Broward, Palm Beach, and Martin counties.

The university’s associates consist of Baptist Health South Florida (including Bethesda Hospital and Boca Raton Regional Hospital), Caridad Centre, Cleveland Clinic Florida, Jupiter Health care Center, Tenet Health care, West Palm Beach VA Health care Procedure, and Palm Beach Atlantic University.

FAU Health was fashioned last 12 months in order to serve as an academic wellbeing network to introduce an increase in resident education systems to the South Florida location.

Furthermore, FAU’s schools of medication and science in October announced an expansion in conjunction with the Max Planck Florida Institute for Neuroscience (MPFI) to offer a neuroscience diploma software that concurrently grants college students a clinical and doctoral degree.

The twin-degree application will run as an accelerated application concerning FAU and MPFI and is expected to get started this 12 months with the first graduations getting put in the spring of 2030, according to the university.

The system can also provide as a recruiting tool for FAU, as it has the only public health care school in the south Florida area. Offered the area’s battle to fulfill health care needs as a consequence of the ongoing overall health worker scarcity, the software can aid meet up with the escalating affected person-care requirements as very well as increase on preexisting analysis infrastructure.

McLaughlin Research Institute plans to establish a clinical research center

Wonderful FALLS — The McLaughlin Analysis Institute for Biomedical Sciences in Good Falls has served a major position in biomedical analysis in Montana for almost 70 decades.

Even though a great deal of their research has concentrated on working with mouse versions as a way to dissect the genetic basis of susceptibility to neurodegenerative diseases, they are on the path in the direction of a a lot more substantial goal, in the hopes that it will provide all types of benefits to the Treasure Condition. That purpose is creating 1 of the nation’s very first rural medical exploration facilities, which will be aimed at expanding clinical investigation in neurodegenerative conditions.

McLaughlin Study Institute Assistant Professor, Tiffany Hensley-McBain mentioned, “There are hundreds of scientific trials enrolling in Alzheimer’s disease correct now, and zero of them are recruiting in Montana. In point, usually, only eight studies on Alzheimer’s disorder have ever enrolled a Montanan.”

McLaughlin Investigate Institute claims the want for medical research growth in the state of Montana has grow to be much more important than at any time. They noted that Montana has regularly rated in the bottom 10{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} when it comes to participation and illustration in medical research nationwide.

They also mentioned that Montana has the sixth oldest population ratio in the nation. A little above 19 percent of our overall inhabitants is around the age of 65.

McLaughlin Investigate Institute says owing to the threat of neurodegenerative ailments growing with age, endorsing the enlargement of science and medicine by way of medical research that targets improvements in prognosis, cure, and avoidance of neurodegenerative diseases is a priority worry.

Clinical Exploration Coordinator, Rebecca Brown stated, “Scientific trials are at the coronary heart of all health-related developments. They are a system by which folks have obtain to the newest and ideal therapy. They also have the opportunity to deliver a whole lot of expertise to the neighborhood, and if we can carry in some clinical investigation on dementia and Alzheimer’s condition, I actually imagine that we can deliver a terrific profit to our state.

In an energy to raise the inclusion and expansion of medical investigation in Montana, McLaughlin Investigation Institute has introduced a registry of possible members for clinical investigation. This registry is open up to any older people of any age or prognosis. The function is to get a checklist of likely individuals for long term investigate research. The registry is referred to as “HERO” (Assisting Grow Investigation Alternatives).

How does the HERO Registry operate:

  • Your get hold of information is securely saved in a HIPAA – compliant database.
  • Minimum details is gathered.
  • Persons may perhaps be contacted if qualified for a examine, and there is no obligation to take part.
  • Any individual of any age and wellbeing position is encouraged to register 

To understand extra, speak to McLaughlin Exploration Institute for Biomedical Science at 406-452-6208, or by clicking in this article.

TRENDING

Adhere to KRTV

Honoris United Universities Achieves International Recognition for Medical Research

Honoris United Universities Achieves International Recognition for Medical Research

Investigation from the revolutionary Honoris Medical Simulation Middle in Tunis was introduced at the Global Assembly on Simulation in Healthcare in Orlando, Usa

We continue to give distinctive obtain to a depth and breadth of cutting-edge simulation expert services that have not been obtainable right before on a pan-regional level”

— Professor Chadli Dziri MD, Director of the Honoris MSC

TUNIS, TUNISIA, January 24, 2023 /EINPresswire.com/ — Honoris United Universities (HUU) attended the world’s premier meeting committed to innovation in the field of health care simulation (IMSH 2023). The Honoris Professional medical Simulation Heart in Tunis, Tunisia presented the results of a randomized managed trial in professional medical simulation carried out at its planet-class facility.

Led by the Culture for Simulation in Healthcare (SSH), the Global Meeting on Simulation in Healthcare (IMSH) is the largest scientific conference devoted to the most up-to-date innovations and most effective techniques in health-related simulation. Chadli DZIRI, MD, FACS, Professor Emeritus of Standard Operation at the Faculty of Medication of Tunis – Tunis El Manar University, Director of the Honoris Medical Simulation Middle, Fellow of the American School of Surgeons, and Member of the Board of Administrators of the American Journal of Surgical treatment, presented at the summit the effects of a randomized controlled demo involving additional than 170 2nd-calendar year Honoris well being university nursing learners, concentrating on health-related pedagogy and evaluating two education approaches: LFS (model) low-fidelity simulation as opposed to standardized individual schooling (SP) for peripheral venous line placement. The abstract of the cross over randomized trial was selected by the SSH organizers. The research protocol has been registered on the Pan African Clinical Demo Registry web site: PACTR202111766112898.

Established in 2018, the cutting-edge Honoris Healthcare Simulation Centre (MSC) is found in the coronary heart of Tunis. It was formulated in coordination with worldwide authorities and utilizing innovative technologies. In 2020, the MSC was a person of the initially centers in Africa to be accredited by SSH: one particular of three accredited facilities among eleven on the continent. The centre provides 4 simulation models like model systems in a hospital setting, state of affairs-primarily based simulations, actor-centered simulations, and cutting-edge virtual truth systems. Far more than 5,000 pupils, 400 health care industry experts, and far more than 60 obstetricians from Northern and Sub-Saharan Africa have been skilled at this facility.

Professor Chadli Dziri MD, Director of the Honoris MSC in Tunis, commented, “Our existence at this year’s IMSH was a wonderful chance to share our finest practice and findings from the use of our know-how and innovative strategies, constantly screening and learning to strengthen each learner and individual results. I am happy that the Honoris Health care Simulation Centre is noticed as a reference issue for international professional medical simulation as we continue on to provide one of a kind obtain to a depth and breadth of slicing-edge simulation services that have not been obtainable in advance of on a pan-regional degree.”

Provided its special network in instruction in Africa, Honoris is fully commited to continuing publishing educational analysis from its facilities of excellence, significantly in the crucial employability sectors for Africa together with well being sciences, organization, and engineering & IT. By encouraging analysis collaborations throughout establishments in numerous markets, Honoris can harness the collective power of its pan-African system and apply health tech remedies and immersive finding out technologies to advance training and finding out in its hubs in Tunisia, Morocco, Nigeria, and South Africa. To continually boost results for its student population of more than 40 nationalities, Honoris plans to broaden its clinical simulation providing to Nigeria and Morocco in the small expression.

Each 12 months, IMSH offers the instruments and resources health care specialists need to advance their abilities, impact change in supply programs and follow, and, in the long run, strengthen individual security. With in excess of 4,000 attendees in 2022, the function welcomes attendees from all about the earth like scientists, academics, medical professionals, and innovators for networking, arms-on workshops, plenary speakers, 300 education periods, and an exhibit hall for the most recent solutions and expert services in the sector.

For Media Info
James Deacon, Communications Manager, Honoris United Universities
jdeacon@honoris.web

James Deacon
Honoris United Universities
email us in this article

You just read through:


EIN Presswire’s precedence is supply transparency. We do not permit opaque clients, and our editors consider to be very careful about weeding out false and misleading written content.
As a person, if you see a thing we have missed, please do carry it to our attention. Your aid is welcome. EIN Presswire, Everyone’s Net Information Presswire™,
attempts to define some of the boundaries that are reasonable in modern environment. Please see our
Editorial Rules
for extra information.

Submit your press release

Motion Capture Tech from Avatar Movies Harnessed for Disease Research

A multi-disciplinary workforce of scientists has produced a way to observe the development of motion issues utilizing movement seize engineering and AI.

In two floor-breaking research, released in Mother nature Medication, a cross-disciplinary workforce of AI and clinical researchers have shown that by combining human movement info gathered from wearable tech with a strong new healthcare AI engineering they are equipped to recognize very clear movement designs, forecast long term ailment progression and noticeably boost the effectiveness of clinical trials in two pretty different unusual issues, Duchenne muscular dystrophy (DMD) and Friedreich’s ataxia (FA).

DMD and FA are rare, degenerative, genetic conditions that influence movement and eventually lead to paralysis. There are at the moment no cures for both condition, but scientists hope that these final results will drastically velocity up the look for for new treatment options. 

Monitoring the progression of FA and DMD is commonly done by means of intense tests in a medical location. These papers offer a substantially much more specific evaluation that also will increase the precision and objectivity of the knowledge gathered. 

The researchers estimate that making use of these illness markers mean that considerably fewer people are necessary to produce a new drug when in contrast to latest strategies. This is specially crucial for rare diseases wherever it can be challenging to detect acceptable patients.

Experts hope that as very well as using the technologies to check patients in scientific trials, it could also one working day be used to watch or diagnose a vary of prevalent health conditions that have an effect on motion habits these kinds of as dementia, stroke and orthopedic circumstances.

In each the FA and DMD reports, all the facts from the movement capture sensors was collected and fed into the AI technologies to create specific avatars and review movements. This large info set and potent computing resource permitted researchers to outline essential motion fingerprints observed in small children with DMD as very well as grown ups with FA, that ended up different in the command group. Several of these AI-primarily based movement styles had not been described clinically just before in both DMD or FA.

Scientists also found out that the new AI approach could significantly boost predictions of how individual patients’ sickness would progress in excess of 6 months in contrast to present gold-standard assessments. These types of a specific prediction lets to operate clinical trials more efficiently so that patients can entry novel therapies quicker, and also help dose drugs more specifically.

The new know-how could enable scientists have out scientific trials of problems that influence movement a lot more quickly and properly. In the DMD study, scientists showed that this new technologies could cut down the figures of young children required to detect if a novel treatment would be working to a quarter of those people necessary with present-day solutions. 

The AI technological innovation applied is particularly impressive when studying unusual health conditions, when affected person populations are more compact. In addition, the technologies allows to review sufferers across lifetime-altering condition situations such as decline of ambulation while current scientific trials concentrate on either ambulant or non-ambulant affected person cohorts.

The work is a outcome of a massive collaboration of scientists and knowledge, throughout AI technological innovation, engineering, genetics and medical specialties. These involve researchers at Imperial College’s Section of Bioengineering and Office of Computing, the Healthcare Study Council London Institute of Professional medical Sciences, the U.K. Analysis and Innovation Centre in AI for Healthcare, College School London (UCL), Fantastic Ormond Road Institute for Youngster Wellness, the Countrywide Institute for Overall health and Treatment Investigation (NIHR) Wonderful Ormond Road Medical center Biomedical Study Centre (BRC), Imperial Higher education London, Ataxia Centre at UCL Queen Square Institute of Neurology, Wonderful Ormond Road Medical center the Countrywide Hospital for Neurology and Neurosurgery, the Countrywide Healthcare facility for Neurology and Neurosurgery, the University of Bayreuth in Germany and the Gemelli Medical center in Rome, Italy.

The research was funded by a UKRI Turing AI Fellowship to Professor Aldo Faisal, NIHR Imperial School Biomedical Analysis Centre, the MRC London Institute of Clinical Sciences, the Duchenne Investigation Fund, the NIHR Wonderful Ormond Avenue Medical center BRC, the UCL/UCLH BRC, and the U.K. Professional medical Investigate Council.

Read more at Imperial Higher education London